article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

(Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. The full presentation is available at: [link]. Highlights from the presentation include: Declining PSA levels in treated patients.

Data 100
article thumbnail

Significant Decrease in Mental Health Treatment Seen in States With Legal Cannabis

Veriheal

States legalizing recreational cannabis are seeing an unexpected and significant decrease in mental health treatment admissions. Ortega’s research meticulously analyzed data from ten states where adult-use cannabis has become legal. Findings of the Study The findings from Ortega’s study are nothing short of illuminating.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit

Cannabis Law Report

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

article thumbnail

Is Irradiation Treatment on Cannabis Too Good to be True?

Medicinal Genomics

Our first thought was that DNA from the dead microbes was still present on the sample after the irradiation treatment. So our working theory became that irradiation treatments don’t actually kill microbes or otherwise disrupt the cell membrane enough to liberate the DNA from the microbial cells. Research by Hieke et al.

Treatment 130
article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

article thumbnail

Press Release: Awakn Life Sciences Files Patent Cooperation Treaty Application for the Treatment of Behavioral Addictions

Cannabis Law Report

Successful Behavioral Addiction Study Supplied Data for Patent. The successful completion of Awakn’s behavioral addictions study was announced last week and the data provided from the study was used in the patent filing. The treatment was also well tolerated with no safety concerns. Awakn Life Sciences Corp. (